LWM
ZOM

Lionsbridge Wealth Management’s Zomedica Corp. ZOM Stock Holding History

Lionsbridge Wealth Management’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,000
Closed -$8K – 59
2021
Q2 		$8K Buy
+10,000
New +$9.32K 0.01% 52

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lionsbridge Wealth Management's ZOM Position: Q3 2021 in Review

Lionsbridge Wealth Management sold out of Zomedica Corp. (ZOM) in Q3 2021, closing a stake of 10,000 shares — an estimated $8K sold.

Lionsbridge Wealth Management first reported a position in ZOM in Q2 2021 and held it in 1 quarter. The position peaked at $8K in Q2 2021. 107 funds tracked by Wall St. Rank hold ZOM as of Q3 2021.

  • Lionsbridge Wealth Management reported no remaining Zomedica Corp. position as of Q3 2021 after selling out during the quarter.
  • Lionsbridge Wealth Management sold 10,000 Zomedica Corp. shares in Q3 2021, an estimated $8K.
  • Lionsbridge Wealth Management first reported a position in Zomedica Corp. in Q2 2021 and held it in 1 quarter.
  • Lionsbridge Wealth Management's Zomedica Corp. position peaked at $8K in Q2 2021.
  • 107 funds tracked by Wall St. Rank held Zomedica Corp. as of Q3 2021.

Based on Lionsbridge Wealth Management's 13F filing for Q3 2021, filed 26 Oct 2021.